Contrast-Enhanced Whole-Heart Coronary Magnetic Resonance Angiography at 3.0-T: A Multicenter Trial

Last updated: July 6, 2011
Sponsor: Capital Medical University
Overall Status: Completed

Phase

N/A

Condition

Hypercholesterolemia

Heart Disease

Chest Pain

Treatment

N/A

Clinical Study ID

NCT01024478
CapitalMedicalU
  • Ages 20-80
  • All Genders

Study Summary

The multicenter study evaluates the diagnostic performance of 3.0 T contrast-enhanced whole-heart coronary MRA in patients with suspected coronary artery disease.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Suspected CAD, scheduled for DSA

  • Sinus rhythm

Exclusion

Exclusion Criteria:

  • Contraindications to MR examination: pacemaker, intraauricular implants, intracranialclips, thoracotomy, claustrophobia, orthopnea

  • Acute coronary syndrome

  • Atria fibrillation

  • Coronary stents

  • Bypass grafts

  • Renal insufficiency (estimated glomerular filtration rate assessed by creatinineclearance <60 ml/min/1.73 m2)

Study Design

Total Participants: 272
Study Start date:
October 01, 2009
Estimated Completion Date:
September 30, 2010

Study Description

This is a multicenter trial evaluated the diagnostic ability of 3.0 T contrast-enhanced whole-heart coronary MRA to detect significant coronary artery stenosis among patients with suspected CAD.

A total of 272 patients will be prospectively enrolled from 8 cities in China.

Connect with a study center

  • Radiology Department of Xuanwu Hopital

    Beijing, Beijing 100053
    China

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.